A Perspective on Imiquimod Microneedles for Treating Warts.

Area of Science:

• Dermatology
• Nanotechnology
• Drug Delivery Systems

Background:

• Warts are common viral skin infections.
• Current treatments involve tissue ablation or cellular division interruption, often causing pain and tissue damage.
• Topical imiquimod shows efficacy for warts but suffers from poor skin permeability and side effects.

Purpose of the Study:

• To develop and evaluate dissolving microneedles loaded with imiquimod for enhanced wart treatment.
• To overcome the limitations of topical imiquimod delivery.
• To explore a minimally invasive and potentially painless therapeutic option.

Main Methods:

• Fabrication of imiquimod-loaded dissolving microneedles using gelatin via a molding method.
• Incorporation of fluorescent dye and trypan blue to assess drug status and microneedle degradation.
• Evaluation of microneedle mechanical strength, skin penetration capability, and in vitro immune response induction.

Main Results:

• Imiquimod-loaded microneedles demonstrated sufficient mechanical strength and skin penetration.
• Gelatin-based microneedles showed effective degradation.
• Imiquimod-loaded microneedles successfully induced immune response in macrophages, comparable to imiquimod alone.

Conclusions:

• Dissolving imiquimod-loaded microneedles represent a promising, minimally invasive approach for wart treatment.
• This technology offers potential for improved drug delivery and reduced side effects compared to conventional methods.
• Further research is warranted to validate this proof-of-concept for clinical application.